0001209191-19-030024.txt : 20190515
0001209191-19-030024.hdr.sgml : 20190515
20190515163538
ACCESSION NUMBER: 0001209191-19-030024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190513
FILED AS OF DATE: 20190515
DATE AS OF CHANGE: 20190515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ciechanover Isaac E.
CENTRAL INDEX KEY: 0001612096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 19828900
MAIL ADDRESS:
STREET 1: C/O ATARA BIOTHERAPEUTICS, INC.
STREET 2: 3260 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-13
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001612096
Ciechanover Isaac E.
611 GATEWAY BOULEVARD
SUITE 900
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Chief Executive Officer
Common Stock
2019-05-13
4
S
0
3500
24.23
D
300837
I
See footnote
Common Stock
2019-05-13
4
S
0
400
24.95
D
300437
I
See footnote
Common Stock
2019-05-14
4
S
0
3900
24.92
D
296537
I
See footnote
Common Stock
332243
D
Transaction pursuant to Rule 10b5-1 Plan adopted January 23, 2018.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $23.75 to $24.62. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Shares are held by the Isaac E. Ciechanover and Allison M. Ciechanover Family Trust dated 8/8/08, of which the Reporting Person is a trustee.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $24.91 to $25.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $24.51 to $25.08. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ David Tucker, Attorney-in-Fact for Isaac E. Ciechanover
2019-05-15